Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Panbela Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 16 | 13 | −3 |
| Shares | 845.3K | 171.4K | −673.9K (−79.7%) |
| Value | $1.78M | $111.0K | −$1.67M (−93.8%) |
New holders (3)
Institutions that held Panbela Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 18,540 | $12.0K | 0.00% |
| Ergoteles LLC | 16,000 | $11.0K | 0.00% |
| Citadel Advisors LLC | 10,793 | $7.00K | 0.00% |
Sold out (6)
Institutions that held Panbela Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ikarian Capital, LLC | 355,959 | $750.0K |
| Vanguard Group Inc | 228,401 | $482.0K |
| Fieldpoint Private Securities, LLC | 62,621 | $132.0K |
| Boothbay Fund Management, LLC | 34,018 | $72.0K |
| BlackRock Inc. | 28,723 | $61.0K |
| Verition Fund Management LLC | 20,000 | $42.0K |